RG
CRL icon

Redmile Group’s Charles River Laboratories CRL Stock Holding History

Redmile Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-86,782
Closed -$20.5M – 78
2023
Q4 		$20.5M Buy
86,782
+20,400
+31% +$4.01M 0.73% 38
2023
Q3 		$13M Sell
66,382
-47,969
-42% -$9.85M 0.62% 37
2023
Q2 		$24M Sell
114,351
-977
-0.8% -$194K 0.92% 33
2023
Q1 		$23.3M Buy
+115,328
New +$26.1M 1.01% 40
2021
Q3 		– Sell
-108,374
Closed -$40.1M – 79
2021
Q2 		$40.1M Sell
108,374
-58,305
-35% -$19.5M 0.59% 46
2021
Q1 		$48.3M Buy
+166,679
New +$46.3M 0.68% 43
2017
Q2 		– Sell
-121,307
Closed -$10.9M – 65
2017
Q1 		$10.9M Sell
121,307
-125,800
-51% -$10.7M 0.71% 46
2016
Q4 		$18.8M Buy
247,107
+120,001
+94% +$9.11M 1.62% 23
2016
Q3 		$10.6M Sell
127,106
-4,500
-3% -$377K 0.84% 31
2016
Q2 		$10.8M Buy
131,606
+21,800
+20% +$1.8M 1.04% 30
2016
Q1 		$8.34M Sell
109,806
-12,594
-10% -$932K 0.85% 30
2015
Q4 		$9.84M Buy
+122,400
New +$8.83M 0.74% 32

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Redmile Group's CRL Position: Q1 2024 in Review

Redmile Group sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 86,782 shares — an estimated $20.5M sold.

Redmile Group first reported a position in CRL in Q4 2015 and held it in 12 quarters. The position peaked at $48.3M in Q1 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.

  • Redmile Group reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
  • Redmile Group sold 86,782 Charles River Laboratories shares in Q1 2024, an estimated $20.5M.
  • Redmile Group first reported a position in Charles River Laboratories in Q4 2015 and held it in 12 quarters.
  • Redmile Group's Charles River Laboratories position peaked at $48.3M in Q1 2021.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.

Based on Redmile Group's 13F filing for Q1 2024, filed 15 May 2024.